- Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA Radioligand Therapy: an Empirical Proof of a Promising Concept
-
Baum RP, Langbein T, Singh A, Shahinfar , Schuchardt C, Volk GF, Kulkarni H
- KMID: 2407306
- Nucl Med Mol Imaging.
- 2018 Feb;52(1):80-81.
- doi: 10.1007/s13139-017-0508-3
The dose-limiting salivary gland toxicity of ²²âµAc-labelled PSMA for treatment of metastatic, castration-resistant prostate cancer remains unresolved. Suppressing the metabolism of the gland by intraparenchymal injections of botulinum toxin appears... -
- CITED
-
- Close
- SHARE
-
- Close
